Pete Littler

Freeman Hospital

Papers

1

Total Citations

14

H-Index

1

About

Pete Littler is a clinician-researcher whose work centers on the surgical and ablative management of rare hepatic tumors, with a particular focus on epithelioid hemangioendothelioma (HEHE). His most cited paper, “Small, incidental hepatic epithelioid haemangioendothelioma: the role of ablative therapy in borderline patients” (2018, 14 citations), addresses a critical clinical dilemma: how to treat these ultra-rare vascular tumors—incidence below 0.1 per 100,000—when they are discovered incidentally. Littler’s contribution lies in demonstrating that ablative therapy offers a viable, less invasive option for borderline surgical candidates, as illustrated through a case of a 70-year-old man with concurrent renal cell carcinoma. This work has shaped management strategies for HEHE, providing evidence that small incidental lesions can be safely treated without major resection. While his citation count is modest, reflecting the niche nature of his field, Littler’s research fills a vital gap in hepatobiliary oncology, offering practical guidance for clinicians facing these rare presentations. His findings underscore the importance of individualized, minimally invasive approaches in complex cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Small, incidental hepatic epithelioid haemangioendothelioma the role of ablative therapy in borderline patients
14 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Freeman Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago